Tetryzolyn |

Release form

Octilia. Eye drops are colorless or light yellow in color, transparent.

Packaging

In 1 dropper bottle, polyethylene 8 ml drops. In a cardboard bundle 1 bottle.

Pharmacological action

Octilia - a drug with a vasoconstrictor effect for topical use in ophthalmology.

Tetrizoline hydrochloride is an alpha-adrenergic agonist derived from imidazole. It has a pronounced vasoconstrictor effect, reduces edema and hyperemia of the mucous membranes.

Chamomile and linden extracts have anti-inflammatory effects.

Indications

As part of complex therapy for the treatment of eye diseases accompanied by symptoms of irritation caused by allergic, chemical and physical factors (smoke, dust, strong lighting, reflection of light from snow and water surfaces, from the emitting monitor screens).

Contraindications

Glaucoma.

Dry eye syndrome.

Epithelial-endothelial dystrophy of the cornea.

Children under 3 years old.

Increased individual sensitivity to the components of the drug.

Caution is advised to prescribe the drug with:

Increased blood pressure.

ischemic heart disease.

Arrhythmias.

Aneurysm.

Severe organic diseases of the heart and blood vessels.

Hyperthyroidism.

Pheochromocytoma.

Diabetes.

During treatment with MAO inhibitors and other drugs that increase blood pressure, antidepressants, during pregnancy and during lactation (breastfeeding).

Use during pregnancy and lactation

Caution should be used to prescribe the drug Octilia during pregnancy and lactation (breastfeeding).

Composition of

1 ml: - tetrizoline hydrochloride 500 mcg

Excipients:

benzalkonium chloride,

disodium phosphate decahydrate,

potassium dihydrogen phosphate,

sodium sulphidlrd, srdldrd, srdlrd, srdlrd, srddrd, srd ,

polysorbate 80,

purified water.

Dosage and administration

The drug is instilled 1-2 drops in the lower conjunctival sac 2-3 times a day.

Side effects

Local reactions: mydriasis, increased intraocular pressure, burning sensation, reactive conjunctival hyperemia.

Systemic reactions: headache, nausea, drowsiness, weakness, tremor, dizziness, insomnia, palpitations, tachycardia, hyperglycemia, increased blood pressure, impaired heart function, allergic reactions.

Drug Interaction

The drug interaction of the drug Octil has not been described.

The drug should not be used concurrently with MAO inhibitors and for 10 days after discontinuation.

Overdose

Symptoms: cyanosis, fever, convulsions, arrhythmias, cardiac arrest, hypertension, pulmonary edema, dyspnoea, CNS depression, accompanied by drowsiness, hypothermia, bradycardia, collapse, collapse.

Keep in mind that the risk of overdose is high in young children, especially when swallowed.

Treatment: Antidote unknown. Appointed activated charcoal, gastric lavage, oxygen inhalation, antipyretic and antiepileptic drugs.

Phentolamine is given at a dose of 5 mg slowly in / in or 100 mg inward to reduce blood pressure.

Storage conditions

The drug should be stored at a temperature not exceeding 25 РC.

Expiration

4 years. After opening the package, the product should be stored for a maximum of 28 days.

Deystvuyuschee substance

tetrisolin

Dosage naya

form Dosage form

eye drops

S.I.F.I. S.p.A., Italy